← Leaderboards
Brian David Modena
Scripps Research Institute, The
$502,472
Attributed
$502,472
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $156.9K · FY2018–21$200K$150K$100K$50K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$502,472 · 1
By mechanism
K23$502,472 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Naiara Akizu$3,703,069
- Shane P Crotty$52,208,511
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultAirway EpitheliumAffectAspirinAspirin-Exacerbated Respiratory DiseaseAsthmaAsiansAsthmaticAsthmatic AirwayAsthmatic PatientAwardBiobankBioinformaticsBiologicalBlood SpecimenAsthma PreventionCaringCellsCharacteristicsChildClinical ResearchCohesionCohortComplement
Grant awards (5)
Genomic Analysis of Epithelial Growth and Repair Mechanisms in Aspirin Exacerbated Respiratory Disease$31,862
K23 · FY2021 · HL · contact PI
Genomic Analysis of Epithelial Growth and Repair Mechanisms in Aspirin Exacerbated Respiratory Disease$156,870
K23 · FY2020 · HL · contact PI
Genomic Analysis of Epithelial Growth and Repair Mechanisms in Aspirin Exacerbated Respiratory Disease$156,870
K23 · FY2019 · HL · contact PI
Genomic Analysis of Epithelial Growth and Repair Mechanisms in Aspirin Exacerbated Respiratory Disease$116,952
K23 · FY2018 · HL · contact PI
Genomic Analysis of Epithelial Growth and Repair Mechanisms in Aspirin Exacerbated Respiratory Disease$39,918
K23 · FY2018 · HL · contact PI